Human immunodeficiency virus associated lymphoma

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose of review: Human immunodeficiency virus (HIV) infection is known to be associated with an increased risk of systemic nonHodgkin lymphoma, Hodgkin disease, and primary central nervous lymphoma (PCNSL). The purpose of this review is to highlight recent advances in the diagnosis and management of lymphoma occurring in patients with HIV infection. Recent findings: Lymphoma occurring in patients with HIV infection has been associated with a very poor prognosis. Recently reported studies have provided new information regarding the influence of highly active antiretroviral therapy (HAART) on the development and clinical presentation of lymphoma, the feasibility of combining HAART with standard chemotherapy, the molecular classification of lymphoma, the role of rituximab in the management of lymphoma, and the use of novel treatment strategies for the treatment of Hodgkin disease. Summary: The improved prognosis for patients with HIV-associated lymphoma in the post-HAART era indicates that therapeutic interventions may be potentially curative, and represent a shift away from therapeutic nihilism and reduced-intensity treatment approaches that have been employed in the recent past.

Original languageEnglish (US)
Pages (from-to)372-378
Number of pages7
JournalCurrent Opinion in Oncology
Volume15
Issue number5
DOIs
StatePublished - Sep 2003

Fingerprint

Lymphoma
HIV
Highly Active Antiretroviral Therapy
Virus Diseases
Hodgkin Disease
Therapeutics
Non-Hodgkin's Lymphoma
Drug Therapy

Keywords

  • AIDS
  • Highly active antiretroviral therapy
  • HIV infection
  • HIV-associated lymphoma
  • Hodkgin disease
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Human immunodeficiency virus associated lymphoma. / Sparano, Joseph A.

In: Current Opinion in Oncology, Vol. 15, No. 5, 09.2003, p. 372-378.

Research output: Contribution to journalArticle

@article{e11d378823ad420b8bd452beeada6c44,
title = "Human immunodeficiency virus associated lymphoma",
abstract = "Purpose of review: Human immunodeficiency virus (HIV) infection is known to be associated with an increased risk of systemic nonHodgkin lymphoma, Hodgkin disease, and primary central nervous lymphoma (PCNSL). The purpose of this review is to highlight recent advances in the diagnosis and management of lymphoma occurring in patients with HIV infection. Recent findings: Lymphoma occurring in patients with HIV infection has been associated with a very poor prognosis. Recently reported studies have provided new information regarding the influence of highly active antiretroviral therapy (HAART) on the development and clinical presentation of lymphoma, the feasibility of combining HAART with standard chemotherapy, the molecular classification of lymphoma, the role of rituximab in the management of lymphoma, and the use of novel treatment strategies for the treatment of Hodgkin disease. Summary: The improved prognosis for patients with HIV-associated lymphoma in the post-HAART era indicates that therapeutic interventions may be potentially curative, and represent a shift away from therapeutic nihilism and reduced-intensity treatment approaches that have been employed in the recent past.",
keywords = "AIDS, Highly active antiretroviral therapy, HIV infection, HIV-associated lymphoma, Hodkgin disease, Non-Hodgkin lymphoma",
author = "Sparano, {Joseph A.}",
year = "2003",
month = "9",
doi = "10.1097/00001622-200309000-00005",
language = "English (US)",
volume = "15",
pages = "372--378",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Human immunodeficiency virus associated lymphoma

AU - Sparano, Joseph A.

PY - 2003/9

Y1 - 2003/9

N2 - Purpose of review: Human immunodeficiency virus (HIV) infection is known to be associated with an increased risk of systemic nonHodgkin lymphoma, Hodgkin disease, and primary central nervous lymphoma (PCNSL). The purpose of this review is to highlight recent advances in the diagnosis and management of lymphoma occurring in patients with HIV infection. Recent findings: Lymphoma occurring in patients with HIV infection has been associated with a very poor prognosis. Recently reported studies have provided new information regarding the influence of highly active antiretroviral therapy (HAART) on the development and clinical presentation of lymphoma, the feasibility of combining HAART with standard chemotherapy, the molecular classification of lymphoma, the role of rituximab in the management of lymphoma, and the use of novel treatment strategies for the treatment of Hodgkin disease. Summary: The improved prognosis for patients with HIV-associated lymphoma in the post-HAART era indicates that therapeutic interventions may be potentially curative, and represent a shift away from therapeutic nihilism and reduced-intensity treatment approaches that have been employed in the recent past.

AB - Purpose of review: Human immunodeficiency virus (HIV) infection is known to be associated with an increased risk of systemic nonHodgkin lymphoma, Hodgkin disease, and primary central nervous lymphoma (PCNSL). The purpose of this review is to highlight recent advances in the diagnosis and management of lymphoma occurring in patients with HIV infection. Recent findings: Lymphoma occurring in patients with HIV infection has been associated with a very poor prognosis. Recently reported studies have provided new information regarding the influence of highly active antiretroviral therapy (HAART) on the development and clinical presentation of lymphoma, the feasibility of combining HAART with standard chemotherapy, the molecular classification of lymphoma, the role of rituximab in the management of lymphoma, and the use of novel treatment strategies for the treatment of Hodgkin disease. Summary: The improved prognosis for patients with HIV-associated lymphoma in the post-HAART era indicates that therapeutic interventions may be potentially curative, and represent a shift away from therapeutic nihilism and reduced-intensity treatment approaches that have been employed in the recent past.

KW - AIDS

KW - Highly active antiretroviral therapy

KW - HIV infection

KW - HIV-associated lymphoma

KW - Hodkgin disease

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0042833018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042833018&partnerID=8YFLogxK

U2 - 10.1097/00001622-200309000-00005

DO - 10.1097/00001622-200309000-00005

M3 - Article

VL - 15

SP - 372

EP - 378

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 5

ER -